Receipt dates: September 8, 2020; January 5, 2021; April 6, 2021
Expires on January 6, 2021
This Funding Opportunity Announcement encourages small businesses to propose commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries, and low-resource settings in the US. Under this opportunity, small businesses are expected to develop or adapt, apply, and validate existing or emerging technologies into user-friendly, low-resource setting-appropriate technologies for cancer prevention, diagnosis, or treatment.
Technologies should be practical and affordable in the low-resource settings, including remote or underserved populations within or outside the US. The technologies may include, but are not limited to tools for vaccine dissemination/delivery, imaging, in vitro diagnosis, or treatment of pre-cancerous (pre-neoplastic) or cancerous lesions that are preventable or treatable within low-resource settings. Strong emphasis is placed on technologies that directly provide or immediately lead to treatment options available in the local health system.
Projects proposed for this opportunity will require multidisciplinary efforts to succeed, and, therefore, all applicant teams must include expertise in oncology, engineering, global health, and healthcare delivery in low-resource settings. Applicants are encouraged to collaborate with academic institutions, local hospitals, community groups, non-governmental organizations, or charities for conduct of the proposed cancer global health product development activities.
Technology areas of interest include, but are not limited to, the following:
Technologies that are generally not appropriate for this FOA include the following:
For more information about this funding opportunity, please contact NCI SBIR Program Director Ming Zhao (email@example.com).